Previously, we demonstrated that solenopsin exhibited anti-angiogenic activity and downregulated phosphoinositol-3 kinase (PI3K) in the p53 deficient renal cell carcinoma cell line 786-O [1]. This evidence concerns the gene TP53 and hereditary clear cell renal cell carcinoma.